What is the update on the Johnson & Johnson's Janssen COVID-19 vaccine?

 

CDC and FDA have recommended a pause in the use of Johnson & Johnson’s (J&J/Janssen) COVID-19 Vaccine in the United States out of an abundance of caution, effective Tuesday, April 13. The Advisory Committee on Immunization Practices (ACIP) will hold its second emergency meeting to discuss J&J/Janssen COVID-19 Vaccine on April 23, 2021. People who have received the J&J/Janssen COVID-19 Vaccine within the past three weeks who develop severe headache, abdominal pain, leg pain, or shortness of breath should seek medical care right away.

 

Related page:

Recommendation to Pause Use of Johnson & Johnson’s Janssen COVID-19 Vaccine